Goldstein Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-739
Closed -$230K 212
2025
Q2
$230K Sell
739
-490
-40% -$187K 0.03% 170
2025
Q1
$643K Buy
1,229
+14
+1% +$7.16K 0.09% 75
2024
Q4
$614K Sell
1,215
-138
-10% -$78.4K 0.09% 80
2024
Q3
$791K Buy
1,353
+60
+5% +$33.9K 0.12% 66
2024
Q2
$658K Buy
1,293
+37
+3% +$18.1K 0.11% 65
2024
Q1
$621K Buy
1,256
+78
+7% +$39.7K 0.11% 69
2023
Q4
$620K Sell
1,178
-32
-3% -$17.1K 0.1% 92
2023
Q3
$610K Buy
1,210
+99
+9% +$48.7K 0.13% 61
2023
Q2
$534K Buy
1,111
+128
+13% +$62.6K 0.11% 71
2023
Q1
$464K Sell
983
-97
-9% -$46.8K 0.1% 76
2022
Q4
$572K Buy
+1,080
New +$572K 0.14% 67

Other funds holding UNH

Goldstein Advisors's UNH Position: Q3 2025 in Review

Goldstein Advisors sold out of UnitedHealth (UNH) in Q3 2025, closing a stake of 739 shares — an estimated $230K sold.

Goldstein Advisors first reported a position in UNH in Q4 2022 and held it in 11 quarters. The position peaked at $791K in Q3 2024. 3,167 funds tracked by Wall St. Rank hold UNH as of Q3 2025.

  • Goldstein Advisors reported no remaining UnitedHealth position as of Q3 2025 after selling out during the quarter.
  • Goldstein Advisors sold 739 UnitedHealth shares in Q3 2025, an estimated $230K.
  • Goldstein Advisors first reported a position in UnitedHealth in Q4 2022 and held it in 11 quarters.
  • Goldstein Advisors's UnitedHealth position peaked at $791K in Q3 2024.
  • 3,167 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2025.

Based on Goldstein Advisors's 13F filing for Q3 2025, filed 21 Oct 2025.